The Enterprise Value as of December 2025 (TTM) for Puma Biotechnology, Inc. (PBYI) is 254.10M

According to Puma Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 254.10M. This represents a change of 41.17% compared to the average of 179.99M of the last 4 quarters.

Puma Biotechnology, Inc. (PBYI) Historical Enterprise Value (quarterly & annually)

How has PBYI Enterprise Value performed in the past?

The mean historical Enterprise Value of Puma Biotechnology, Inc. over the last ten years is 940.09M. The current 254.10M Enterprise Value has changed 2.60% with respect to the historical average. Over the past ten years (40 quarters), PBYI's Enterprise Value was at its highest in in the September 2017 quarter at 4.38B. The Enterprise Value was at its lowest in in the September 2024 quarter at 144.08M.

Puma Biotechnology, Inc. (PBYI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Puma Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Puma Biotechnology, Inc. (PBYI) Average Enterprise Value

How has PBYI Enterprise Value performed in the past?

The current Enterprise Value of Puma Biotechnology, Inc. (PBYI) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Puma Biotechnology, Inc. (PBYI) Enterprise Value vs. Peers

How is PBYI’s Enterprise Value compared to its peers?

Puma Biotechnology, Inc.’s Enterprise Value is greater than Eledon Pharmaceuticals, Inc. (92.37M), greater than Abeona Therapeutics Inc. (184.72M), greater than Voyager Therapeutics, Inc. (235.09M), greater than Atea Pharmaceuticals, Inc. (154.94M), greater than Arcturus Therapeutics Holdings Inc. (26.78M), less than Allogene Therapeutics, Inc. (362.93M), greater than Humacyte, Inc. (196.00M), less than Entrada Therapeutics, Inc. (347.42M), greater than Sagimet Biosciences Inc. (164.48M),

Build a custom stock screener for Puma Biotechnology, Inc. (PBYI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Puma Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Puma Biotechnology, Inc. (PBYI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Puma Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.